Last reviewed · How we verify
Malignant tumor of pancreas
Approved treatments
- Lynparza · University of Texas Southwestern Medical Center
- Lynparza · AstraZeneca
Lynparza blocks the repair of DNA damage in cancer cells by inhibiting the enzyme PARP.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of pancreas patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of pancreas treatment landscape brief
- Malignant tumor of pancreas treatment updates RSS
Frequently asked questions about Malignant tumor of pancreas
What drugs treat Malignant tumor of pancreas?
Tracked treatments include Lynparza.
What is the treatment for Malignant tumor of pancreas?
Standard treatment for Malignant tumor of pancreas includes Lynparza. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of pancreas patent cliff · Malignant tumor of pancreas CI report
- Treatment: Lynparza · University of Texas Southwestern Medical Center
- Treatment: Lynparza · AstraZeneca
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing